推荐产品
一般描述
The progesterone receptor (PgR) is an estrogen-regulated protein. It has been proposed that expression of PgR determination indicates a responsive estrogen receptor (ER) pathway. A number of studies have shown that PgR determination provides supplementary information to ER.
Progesterone receptor (PGR) belongs to the steroid/thyroid hormone receptor family of ligand-activated transcription factors. It possesses the amino-terminal AF1 region, the central DNA-binding domain (DBD) and the carboxyl-terminal ligand- binding domain (LBD). The PGR gene is localized on human chromosome 11q22.1.
Progesterone receptor (PGR) belongs to the steroid/thyroid hormone receptor family of ligand-activated transcription factors. It possesses the amino-terminal AF1 region, the central DNA-binding domain (DBD) and the carboxyl-terminal ligand- binding domain (LBD). The PGR gene is localized on human chromosome 11q22.1.
免疫原
Recombinant protein encoding aa 412-526 of human progesterone receptor.
生化/生理作用
Progesterone receptor (PGR) functions as a transcription factor,
which modulates the transcription of target genes in response to progesterone and other hormones. It is phosphorylated on multiple sites and at times, the phosphorylation changes according to the hormone involved. During hormone unavailability, PGR is bound to heat shock proteins. When the ligand binds, it causes the release of PGR from heat shock proteins. It is then translocated to the nucleus, where it binds to its DNA response elements (SREs) and to the components of the transcription machinery. PGR also binds to chromatin templates and results in chromatin remodeling adjacent to the PGR-binding sites.
which modulates the transcription of target genes in response to progesterone and other hormones. It is phosphorylated on multiple sites and at times, the phosphorylation changes according to the hormone involved. During hormone unavailability, PGR is bound to heat shock proteins. When the ligand binds, it causes the release of PGR from heat shock proteins. It is then translocated to the nucleus, where it binds to its DNA response elements (SREs) and to the components of the transcription machinery. PGR also binds to chromatin templates and results in chromatin remodeling adjacent to the PGR-binding sites.
特点和优势
Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.
外形
0.1 ml rabbit monoclonal antibody supplied as tissue culture supernatant in TBS/1% BSA buffer pH 7.5 with less than 0.1% sodium azide.
免责声明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
储存分类代码
10 - Combustible liquids
WGK
WGK 2
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
Human molecular genetics, 29(20), 3412-3430 (2020-10-20)
Although ARID1A mutations are a hallmark feature, mutations in other SWI/SNF (SWItch/Sucrose Non-Fermentable) chromatin remodeling subunits are also observed in endometrial neoplasms. Here, we interrogated the roles of Brahma/SWI2-related gene 1 (BRG1, SMARCA4), the SWI/SNF catalytic subunit, in the endometrial
Cells, 11(6) (2022-03-26)
Endometrial cancer (EC) is characterized by high estrogen levels unopposed by progesterone. Treatment with progestins is standard for early EC, but the response to progestins is dependent on progesterone receptor (PGR) expression. Here, we show that the expression of PGR
Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women.
Breast Cancer Research and Treatment, 139(3), 833-843 (2013)
International journal of molecular sciences, 23(23) (2022-12-12)
Women with complex atypical hyperplasia (CAH) or early-stage endometrioid endometrial cancer (EEC) are candidates for fertility preservation. The most common approach is progesterone (P4) therapy and deferral of hysterectomy until after completion of childbearing. However, P4 therapy response rates vary
Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo.
Molecular Endocrinology, 11(6), 823-832 (1997)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门